These Patients May Be Less Adherent to nAMD Treatment

This post was originally published on Medscape

You will shortly be re-directed to the publisher's website

Patients with neovascular age-related macular degeneration diagnosed by a primary care clinician may be more likely to miss anti-VEGF treatments.
Medscape Medical News